Sign in
BCLI Stock Price, Chart, Stats & News
Brainstorm Cell Therapeutics Inc.
Save
Brainstorm Cell Therapeutics Inc. (BCLI) does not currently pay a dividend.
10.81M
Market cap
–
Current P/E
–
Forward P/E
BCLI chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform.
Similar securities
Based on sector and market capitalization
Report issue